Eileen Berry

Eileen Berry has extensive experience in regulatory writing, currently serving as Associate Director of Regulatory Writing at AbbVie since January 2020 and as Associate Director of Regulatory Medical Writing at Pharmacyclics since May 2013. Eileen has held various roles in medical writing, including Manager and Principal Medical Writer, with responsibilities encompassing the preparation of clinical study reports and regulatory submissions. Previous positions include Regulatory Writing Consultant at ERB Communications, Senior Submissions Writer at Novartis Pharma AG, and Senior Medical Writer at Health Interactions and Arpida. Eileen's educational background includes a Certificate with Distinction from Harvard Medical School and a Ph.D/M.Sc. in Microbiology and Molecular Biology from New York University.